Nivolumab Plus Chemotherapy or Ipilimumab in Gastro-Oesophageal Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Nivolumab plus chemotherapy or ipilimumab in gastro-oesophageal cancer
Nature 2022 Mar 01;603(7903)942-948, K Shitara, JA Ajani, M Moehler, M Garrido, C Gallardo, L Shen, K Yamaguchi, L Wyrwicz, T Skoczylas, AC Bragagnoli, T Liu, M Tehfe, E Elimova, R Bruges, T Zander, S de Azevedo, R Kowalyszyn, R Pazo-Cid, M Schenker, JM Cleary, P Yanez, K Feeney, MV Karamouzis, V Poulart, M Lei, H Xiao, K Kondo, M Li, YY JanjigianFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.